Skip to main content
OpenTrials

Clinical trial condition

Intestinal Diseases

Explore clinical trials studying Intestinal Diseases. Study availability and eligibility vary by location and protocol.

11,737 public trials 2,242 recruiting studies
Refine in advanced search Browse all conditions

Intestinal Diseases trial results

Active, Not Recruiting

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

NCT04929028

Conditions
AIDS-Related Anal Carcinoma, Anal Margin Squamous Cell Carcinoma, Anal Non-Keratinizing Squamous Cell Carcinoma, +34 more
Locations
  • Zuckerberg San Francisco General Hospital San Francisco, California, United States
  • George Washington University Medical Center Washington D.C., District of Columbia, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Illinois Chicago, Illinois, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

NCT04704661

Conditions
Advanced Breast Carcinoma, Advanced Colon Carcinoma, Advanced Colorectal Carcinoma, +80 more
Locations
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

Testing a Combination of Vaccines for Cancer Prevention in Lynch Syndrome

NCT05419011

Conditions
Colonic Diseases, Colorectal Carcinoma, Colorectal Neoplasm, +18 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • University of Arizona Cancer Center - Prevention Research Clinic Tucson, Arizona, United States
  • UCSF Medical Center-Parnassus San Francisco, California, United States
  • UCHealth University of Colorado Hospital Aurora, Colorado, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation

NCT06106308

Conditions
CRC, Colonic Diseases, Colorectal Neoplasms, +11 more
Locations
  • Mayo Clinic - Arizona Phoenix, Arizona, United States
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • St. Bernards Medical Center Jonesboro, Arkansas, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
View all 41 locations
View Trial Details

Related conditions